Alginate Particles as Platform for Drug Delivery by the Oral Route: State-of-the-Art

<table>Animal survival profile over 17 weeks. Control group animals gavaged with drug-free ALG-chitosan microcapsules suspended in PBS and treatment group animals gavaged with microencapsulated oxaliplatin nanoparticles suspended in PBS. Reproduced from [<a href="/journals/isrn/2014/926157/#B91">91</a>] with permission of Elsevier.</table>

International Scholarly Research Notices

fig6

Figure 6

Figure 6: Alginate Particles as Platform for Drug Delivery by the Oral Route: State-of-the-Art 